| Dec 4 2014 |
Group Purchasing Organization (GPO) Fees Under Scrutiny by the GAO (Government Accountability Office) |
Mintz |
| Dec 4 2014 |
Court-Appointed Experts: The Future of Litigation? |
IMS Legal Strategies |
| Dec 4 2014 |
President Obama’s Executive Action and the Agricultural Sector |
Michael Best & Friedrich LLP |
| Dec 4 2014 |
An Update on EPA’s Approach to Methane Emissions from the Oil & Gas Sector – Including a Summary of the Agency’s Proposed New Reporting Rule |
McDermott Will & Emery |
| Dec 2 2014 |
Prosecutorial Over-Criminalization: Fishing for Guilty Pleas |
Barnes & Thornburg LLP |
| Dec 2 2014 |
Health Care Law Update - December 1, 2014 |
Mintz |
| Dec 1 2014 |
Significant Number of Dawn Raids Shows Increased Antitrust and Criminal Law Enforcement in Italian Pharmaceutical Sector |
McDermott Will & Emery |
| Nov 28 2014 |
Brazil: An Update of the Most Relevant Events for Pharmaceutical Companies in 2014: Part 3 of a 5-Part Series |
Michael Best & Friedrich LLP |
| Nov 26 2014 |
Ineligible Subject Matter in One Court Is Still Ineligible in Another |
McDermott Will & Emery |
| Nov 26 2014 |
No En Banc Review for Use of Post Invention Information in Obviousness Analysis |
McDermott Will & Emery |
| Nov 26 2014 |
Federal Circuit: District Courts Should Not Nit-PIC (Patents) |
McDermott Will & Emery |
| Nov 25 2014 |
Energy and Environment Law Update: Week of 11/24/2014 |
Mintz |
| Nov 24 2014 |
Cybersecurity Litigation Monthly Newsletter-November 2014 |
Faegre Drinker |
| Nov 21 2014 |
Purdue Pharma L.P. v. Depomed, Inc., Denying Motion to Seal and Joint Motion for Protective Order IPR2014-00377; IPR2014-00378; IPR2014-00379 |
Faegre Drinker |
| Nov 21 2014 |
Faulty Damages Model Leads to Partial Decertification in California |
Sheppard, Mullin, Richter & Hampton LLP |
| Nov 21 2014 |
The German Supreme Administrative Court Confirms That E-Cigarettes Are Not Medicines Or Medical Devices |
Covington & Burling LLP |
| Nov 21 2014 |
FERC Orders ISOs (Independent System Operators) to Address Fuel Assurance Issues 149 FERC ¶ 61,145 (2014) |
Bracewell LLP |
| Nov 20 2014 |
D.C. Circuit Upholds Contraceptive Coverage Mandate |
Mintz |
| Nov 20 2014 |
Africa: Realizing the Potential to Become the Breadbasket of the World |
Greenberg Traurig, LLP |
| Nov 20 2014 |
Antares Pharma Bolsters the “Original Patent” Rule for Reissued Patents |
Michael Best & Friedrich LLP |
| Nov 20 2014 |
Health Resources and Services Administration (HRSA) Withdraws 340B Program Proposed Rule |
McDermott Will & Emery |
| Nov 20 2014 |
Recent Trends in Medical Device Patent Litigation at the ITC: Part 3 |
Covington & Burling LLP |
| Nov 20 2014 |
Vascular Solutions Inc. and its CEO Face Criminal Charges for Selling Unapproved Medical Devices |
Mintz |
| Nov 20 2014 |
A Report from the “Biosimilars and Biotech: MENA Conference” in Istanbul, Turkey: Part 1 |
Michael Best & Friedrich LLP |
| Nov 19 2014 |
CPSC Focusing on Three Areas for Reduction of CPSIA Testing Burdens |
Mintz |
| Nov 19 2014 |
Comments Sought by December 19th on the FDA's Proposed Criteria for "First Generic" Applications |
Katten |
| Nov 19 2014 |
The 340B Mega-Reg is Dead re: Drug Discount Program |
Mintz |
| Nov 19 2014 |
Mirror, Mirror on Your App…The Cosmetics Industry Embraces Digital |
Covington & Burling LLP |
| Nov 18 2014 |
Telehealth/Telemedicine: An Opportunity for Physicians and Providers to Add a New Line of Service |
McBrayer, McGinnis, Leslie and Kirkland, PLLC |
| Nov 17 2014 |
Health Insurer Antitrust Claim Against Drug Company Remanded to State Court |
Dickinson Wright PLLC |
| Nov 15 2014 |
Potential Minimum Wage Exposure for California Employees Paid on Commission/Piece-Rate Basis |
Morgan, Lewis & Bockius LLP |
| Nov 14 2014 |
A Taste of Things to Come? Whole Foods Feels Sting of “Non-GMO” Litigation |
Mintz |
| Nov 13 2014 |
Supreme Court to Decide Important Administrative Law Issue |
McDermott Will & Emery |
| Nov 13 2014 |
Contaminated Oysters in Virginia Restaurant Enough for Jurisdiction Under "Stream of Commerce" Test |
Womble Bond Dickinson (US) LLP |
| Nov 12 2014 |
California Life Science Company Pays $55 Million in FCPA (Foreign Corrupt Practices Act) Settlement |
Steptoe & Johnson PLLC |
